Vukovich R A, Dreyfuss J, Schreiber E C, Neiss E S
Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):182-6.
A single oral dose of 10 mg of SQ 10,996-14C was absorbed slowly by 3 normal male volunteers, with peak plasma concentrations achieved 6 hr after ingestion; the plasma half-life was about 38.5 hr. On average, 82.3 +/- 3.5% of the radioactivity present in the 2 hr plasma sample was bound to plasma proteins. These volunteers excreted an average of 31 and 52% of the dose in the urine and feces, respectively. All subjects excreted minor amounts of 14CO2 in the expired air. No unchanged SQ 10,996-14C was found in the urine. Three unidentified metabolites were excreted in urine. SQ 10,996-14C was excreted in the feces only as unchanged drug, suggesting that the drug is incompletely absorbed. The volunteers tolerated the drug well and experienced no adverse effects.
3名正常男性志愿者口服10毫克的SQ 10,996 - 14C单剂量后,吸收缓慢,服药后6小时达到血浆峰值浓度;血浆半衰期约为38.5小时。平均而言,服药后2小时血浆样本中82.3±3.5%的放射性与血浆蛋白结合。这些志愿者分别平均在尿液和粪便中排泄了31%和52%的给药剂量。所有受试者呼出的气体中均排出少量的14CO2。尿液中未发现未代谢的SQ 10,996 - 14C。尿液中排泄出三种未鉴定的代谢物。SQ 10,996 - 14C仅以未代谢药物的形式排泄到粪便中,表明该药物吸收不完全。志愿者对该药物耐受性良好,未出现不良反应。